Glucose-sensitive nanoparticle for cancer diagnosis and therapy
US-2015374828-A1 · Dec 31, 2015 · US
US10086090B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10086090-B2 |
| Application number | US-201715438047-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 21, 2017 |
| Priority date | Jan 28, 2010 |
| Publication date | Oct 2, 2018 |
| Grant date | Oct 2, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention aims at providing a novel indocyanine compound solving problems of conventionally used indocyanine green, such as solubility in water or physiological saline, a synthesis method and a purification method thereof, and a diagnostic composition including the novel indocyanine compound. Further, provided are a method for evaluating biokinetics of the novel indocyanine compound and a device for measuring biokinetics, and a method and a device for visualizing circulation of fluid such as blood in a living body, which utilize the diagnostic composition. Also, found are a novel indocyanine compound in which a hydrophobic moiety in a near-infrared fluorescent indocyanine molecule is included in a cavity of a cyclic sugar chain cyclodextrin to cover the hydrophobic moiety in the indocyanine molecule with the glucose, and a synthesis method and a purification method thereof. Furthermore, found are a method for fluorescence-imaging an organ other than liver by intravenous administration, a method for evaluating biokinetics of the novel indocyanine compound, a device for measuring biokinetics, and a method and a device for visualizing circulation of fluid such as blood in a living body, utilizing the diagnostic composition including the novel indocyanine compound.
Opening claim text (preview).
The invention claimed is: 1. A cyclodextrin-bonded indocyanine cation of formula (15), (16), (19) or (20): wherein in the formulas (16) and (20), the indocyanine structure has at least a portion of a naphthyl group included in a cavity of a cyclodextrin. 2. The cyclodextrin-bonded indocyanine cation of claim 1 , which has the formula (15) or (16). 3. The cyclodextrin-bonded indocyanine cation of claim 1 , which has the formula (19) or (20). 4. A composition, comprising: the cyclodextrin-bonded indocyanine cation of claim 1 . 5. The composition of claim 4 , further comprising: water. 6. The composition of claim 5 , wherein the cyclodextrin-bonded indocyanine cation has the formula (15) or (16). 7. The composition of claim 5 , wherein the cyclodextrin-bonded indocyanine cation has the formula (19) or (20). 8. The composition of claim 4 , which is in a form capable of being dissolved in water to provide an aqueous solution. 9. The composition of claim 8 , wherein the cyclodextrin-bonded indocyanine cation has the formula (15) or (16). 10. The composition of claim 8 , wherein the cyclodextrin-bonded indocyanine cation has the formula (19) or (20). 11. A solid cyclodextrin-bonded indocyanine of formula (16) or (20): wherein in the formulas (16) and (20), the indocyanine structure has at least a portion of a naphthyl group included in a cavity of a cyclodextrin. 12. The solid cyclodextrin-bonded indocyanine of claim 11 , which has the formula (20). 13. The solid cyclodextrin-bonded indocyanine of claim 12 , which has an ESI-MS m/z [M] value corresponding to a molecular formula C 135 H 197 N 4 O 73 . 14. The solid cyclodextrin-bonded indocyanine of claim 12 , which is produced by a method including mixing a compound of formula (18) with a compound of formula (14) in a medium to obtain a mixture: mixing a dehydration-condensing agent with the mixture to perform a dehydration-condensation reaction of the mixture, and optionally performing an inclusion reaction in water. 15. The solid cyclodextrin-bonded indocyanine of claim 12 , which is produced by purification through column chromatography and elution with a medium including an acid selected from the group consisting of hydrochloric acid, trifluoroacetic acid, acetic acid, sulfuric acid, nitric acid and formic acid. 16. The solid cyclodextrin-bonded indocyanine of claim 12 , which is produced by purification through column chromatography and elution with a medium including hydrochloric acid. 17. The solid cyclodextrin-bonded indocyanine of claim 11 , which has the formula (16). 18. The solid cyclodextrin-bonded indocyanine of claim 17 , which has a ESI-MS m/z [M] + value corresponding to a molecular formula C 131 H 191 N 4 O 72 . 19. The solid cyclodextrin-bonded indocyanine of claim 17 , which is produced by a method including mixing a compound of formula (13) with a compound of formula (14) in a medium to obtain a mixture: mixing a dehydration-condensing agent with the mixture to perform a dehydration-condensation reaction of the mixture, and optionally performing an inclusion reaction in water. 20. The solid cyclodextrin-bonded indocyanine of claim 17 , which is produced by purification through column chromatography and elution with a medium including an acid selected from the group consisting of hydrochloric acid, trifluoroacetic acid, acetic acid, sulfuric acid, nitric acid and formic acid. 21. The solid cyclodextrin-bonded indocyanine of claim 17 , which is produced by purification through column chromatography and elution with a medium including hydrochloric acid. 22. A composition, comprising: the solid cyclodextrin-bonded indocyanine of claim 11 . 23. The composition of claim 22 , wherein the solid cyclodextrin-bonded indocyanine has the formula (20). 24. The composition of claim 22 , wherein the solid cyclodextrin-bonded indocyanine has the formula (16).
Fluorescence in vivo · CPC title
lymph vessels, ducts or nodes · CPC title
more than five >CH- groups · CPC title
by measuring fluorescence emission · CPC title
Substituted non-aromatic cyclic groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.